TotalMarketCap

TRex Bio

TRXBNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$418.272 M

$15.24 +5.54%

Close of 22 Oct 2026

As of 22 Oct 2026, TRex Bio (TRXB) has a market capitalization of $418.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 162 →
  1. #70Autolus TherapeuticsAUTL$431.2M
  2. #71Tectonic TherapeuticTECX$427.0M
  3. #72TRex BioTRXB$418.3M
  4. #73Zura BioZURA$395.8M
  5. #74C4 TherapeuticsCCCC$390.0M

What if TRex Bio were worth as much as…

Open the what-if tool →

Gold $27.9T

$1,018,360

Per share 66,821× higher

Bitcoin $1.63T

$59,566.59

Per share 3,909× higher

Nvidia $5.35T

$194,911.43

Per share 12,789× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for TRex Bio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Oct 2026. Read the methodology.